164 related articles for article (PubMed ID: 35550826)
1. Early improvement as a predictor of final remission in patients with treatment-resistant depression receiving electroconvulsive therapy with ketofol anesthesia.
Zheng W; He M; Gu LM; Lao GH; Wang DF; Mai JX; Wu HW; Nie S; Huang X
J Affect Disord; 2022 Aug; 310():223-227. PubMed ID: 35550826
[TBL] [Abstract][Full Text] [Related]
2. Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy.
Lin CH; Chen MC; Yang WC; Lane HY
Eur Neuropsychopharmacol; 2016 Feb; 26(2):225-233. PubMed ID: 26718791
[TBL] [Abstract][Full Text] [Related]
3. BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study.
Huang XB; Huang X; He HB; Mei F; Sun B; Zhou SM; Yan S; Zheng W; Ning Y
Neuropsychiatr Dis Treat; 2020; 16():901-908. PubMed ID: 32308393
[TBL] [Abstract][Full Text] [Related]
4. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression.
Zhong X; He H; Zhang C; Wang Z; Jiang M; Li Q; Zhang M; Huang X
J Affect Disord; 2016 Sep; 201():124-30. PubMed ID: 27208499
[TBL] [Abstract][Full Text] [Related]
5. Improvement after two sessions of electroconvulsive therapy predicts final remission in in-patients with major depression.
Birkenhager TK; Roos J; Kamperman AM
Acta Psychiatr Scand; 2019 Sep; 140(3):189-195. PubMed ID: 31104321
[TBL] [Abstract][Full Text] [Related]
6. Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT.
Lin HS; Lin CH
J Affect Disord; 2019 Feb; 245():91-97. PubMed ID: 30368075
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of electroconvulsive therapy (ECT) plus agomelatine to ECT plus placebo in treatment-resistant depression.
Lin CH; Yang WC; Chen CC; Cai WR
Acta Psychiatr Scand; 2020 Aug; 142(2):121-131. PubMed ID: 32412097
[TBL] [Abstract][Full Text] [Related]
8. Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial.
Altinay M; Karne H; Anand A
Psychopharmacol Bull; 2019 Feb; 49(1):8-16. PubMed ID: 30858635
[TBL] [Abstract][Full Text] [Related]
9. Early improvement in HAMD-17 and HAMD-7 scores predict response and remission in depressed patients treated with fluoxetine or electroconvulsive therapy.
Lin CH; Park C; McIntyre RS
J Affect Disord; 2019 Jun; 253():154-161. PubMed ID: 31035216
[TBL] [Abstract][Full Text] [Related]
10. Ketamine Anesthesia, Efficacy of Electroconvulsive Therapy, and Cognitive Functions in Treatment-Resistant Depression.
Rybakowski JK; Bodnar A; Krzywotulski M; Chlopocka-Wozniak M; Michalak M; Rosada-Kurasinska J; Bartkowska-Sniatkowska A
J ECT; 2016 Sep; 32(3):164-8. PubMed ID: 27008330
[TBL] [Abstract][Full Text] [Related]
11. Effects of Low-Dose Ketamine on the Antidepressant Efficacy and Suicidal Ideations in Patients Undergoing Electroconvulsive Therapy.
Chen Q; Dong J; Luo J; Ren L; Min S; Hao X; Luo Q; Chen J; Li X
J ECT; 2020 Mar; 36(1):25-30. PubMed ID: 31913927
[TBL] [Abstract][Full Text] [Related]
12. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
[TBL] [Abstract][Full Text] [Related]
13. Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT).
Ekstrand J; Fattah C; Persson M; Cheng T; Nordanskog P; Åkeson J; Tingström A; Lindström MB; Nordenskjöld A; Movahed Rad P
Int J Neuropsychopharmacol; 2022 May; 25(5):339-349. PubMed ID: 35020871
[TBL] [Abstract][Full Text] [Related]
14. Ketamine-based anesthesia improves electroconvulsive therapy outcomes: a randomized-controlled study.
Gamble JJ; Bi H; Bowen R; Weisgerber G; Sanjanwala R; Prasad R; Balbuena L
Can J Anaesth; 2018 Jun; 65(6):636-646. PubMed ID: 29700801
[TBL] [Abstract][Full Text] [Related]
15. Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study.
Zheng W; Cen Q; Nie S; Li M; Zeng R; Zhou S; Cai D; Jiang M; Huang X
PeerJ; 2021; 9():e10699. PubMed ID: 33604173
[TBL] [Abstract][Full Text] [Related]
16. Early improvement as a predictor of final remission in major depressive disorder: New insights in electroconvulsive therapy.
Martínez-Amorós E; Goldberg X; Gálvez V; de Arriba-Arnau A; Soria V; Menchón JM; Palao DJ; Urretavizcaya M; Cardoner N
J Affect Disord; 2018 Aug; 235():169-175. PubMed ID: 29656263
[TBL] [Abstract][Full Text] [Related]
17. Actigraphy in patients with treatment-resistant depression undergoing electroconvulsive therapy.
Winkler D; Pjrek E; Lanzenberger R; Baldinger P; Eitel D; Kasper S; Frey R
J Psychiatr Res; 2014 Oct; 57():96-100. PubMed ID: 24998016
[TBL] [Abstract][Full Text] [Related]
18. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
[TBL] [Abstract][Full Text] [Related]
19. The superiority of ketofol and etomidate against propofol or thiopental anesthesia for ECT.
Gurel SC; Ozden HC; Karahan S; Ayhan Y
Asian J Psychiatr; 2022 Jun; 72():103090. PubMed ID: 35390580
[TBL] [Abstract][Full Text] [Related]
20. ECT non-remitters: prognosis and treatment after 12 unilateral electroconvulsive therapy sessions for major depression.
van Duist M; Spaans HP; Verwijk E; Kok RM
J Affect Disord; 2020 Jul; 272():501-507. PubMed ID: 32553394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
